Forefront Analytics’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,191
Closed -$254K 72
2020
Q4
$254K Buy
5,191
+685
+15% +$33.8K 0.11% 50
2020
Q3
$226K Sell
4,506
-47
-1% -$2.42K 0.11% 47
2020
Q2
$233K Buy
4,553
+4,505
+9,385% +$219K 0.14% 48
2020
Q1
$2.1K Buy
+48
New +$2.3K ﹤0.01% 105

Other funds holding SNY

Forefront Analytics's SNY Position: Q1 2021 in Review

Forefront Analytics sold out of Sanofi (SNY) in Q1 2021, closing a stake of 5,191 shares — an estimated $254K sold.

Forefront Analytics first reported a position in SNY in Q1 2020 and held it in 4 quarters. The position peaked at $254K in Q4 2020. 572 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Forefront Analytics reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
  • Forefront Analytics sold 5,191 Sanofi shares in Q1 2021, an estimated $254K.
  • Forefront Analytics first reported a position in Sanofi in Q1 2020 and held it in 4 quarters.
  • Forefront Analytics's Sanofi position peaked at $254K in Q4 2020.
  • 572 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Forefront Analytics's 13F filing for Q1 2021, filed 13 May 2021.